Expansion of the CCR Aquatics Facility for cell signaling research
FY24 FACILITIES TO E - W2F2 CCR AQUATICS FACILITY EXPANSION AND OFFICES ROOMS
This study is all about improving a research facility to help scientists better understand how cells communicate, which could eventually lead to new treatments that benefit patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11219244 on NIH RePORTER |
What this research studies
This project focuses on expanding the CCR Aquatics Facility to enhance research capabilities in cell communication and signaling. The expansion includes converting existing rooms into offices and conference spaces, as well as refurbishing laboratories to support established investigators. This will create a more conducive environment for research activities related to cell signaling and development. Patients may benefit indirectly from advancements in understanding cellular processes that could lead to new treatments.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions related to cell signaling abnormalities.
Not a fit: Patients with conditions unrelated to cell signaling or those not involved in research activities at the facility may not receive direct benefits.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in understanding cell signaling, potentially resulting in new therapeutic strategies for various diseases.
How similar studies have performed: While this specific facility expansion is a logistical improvement, similar research in cell signaling has shown promise in advancing our understanding of cellular processes.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.